[
  {
    "section": "section:1",
    "title": "Baseline Plasma Proteomic Analysis to Identify Biomarkers that Predict Radiation-Induced Lung Toxicity in Patients Receiving Radiation for Non-small Cell Lung Cancer"
  },
  {
    "section": "section:2",
    "title": "PATIENTS AND METHODS"
  },
  {
    "section": "section:3",
    "title": "Study Population"
  },
  {
    "section": "section:3",
    "title": "Plasma Sample Preparation"
  },
  {
    "section": "section:3",
    "title": "Proteomic Analysis"
  },
  {
    "section": "section:3",
    "title": "Western Blotting for Validation"
  },
  {
    "section": "section:3",
    "title": "Statistical Considerations"
  },
  {
    "section": "section:2",
    "title": "RESULTS"
  },
  {
    "section": "section:3",
    "title": "Patient Characteristics"
  },
  {
    "section": "section:3",
    "title": "Reproducibility of the Proteomics System"
  },
  {
    "section": "section:3",
    "title": "Plasma Proteomic Analysis between Patients with and without RILT2"
  },
  {
    "section": "section:3",
    "title": "Validation by Western Blotting"
  },
  {
    "section": "section:3",
    "title": "Predictive Models for Risk of RILT2"
  },
  {
    "section": "section:2",
    "title": "DISCUSSION"
  },
  {
    "section": "section:2",
    "title": "ACKNOWLEDGMENTS"
  },
  {
    "section": "section:2",
    "title": "REFERENCES"
  }
]